Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.41 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.32 |
| ▸ | AMD1 | P17707 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13855569 | 0.85 | ADORA2A (0.39) | ADORA2AADORA2BTLR7 | |
| SCHEMBL3888524 | 0.83 | ADORA2A (0.59) | ADORA2AADORA2B | |
| SCHEMBL13855563 | 0.81 | ADORA3 (0.39) | ADORA2AAMD1 | |
| SCHEMBL13855562 | 0.79 | ADORA2A (0.49) | ADORA2AADORA2BAMD1 | |
| SCHEMBL4239724 | 0.72 | ADORA2A (0.51) | ADORA2AADORA2B | |
| SCHEMBL3882647 | 0.72 | ADORA2A (0.54) | ADORA2AADORA2B | |
| SCHEMBL3880247 | 0.71 | ADORA2A (0.48) | ADORA2AADORA2B | |
| SCHEMBL4239470 | 0.71 | ADORA2A (0.48) | ADORA2AADORA2B | |
| SCHEMBL4239465 | 0.71 | ADORA2A (0.48) | ADORA2AADORA2B | |
| SCHEMBL4031221 | 0.70 | ADORA2A (0.50) | ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090118220-A1 | SUBSTITUTED ADENINES AND THE USES THEREOF | ASTRAZENECA AB (SE) | 2009-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118220-A1 | SUBSTITUTED ADENINES AND THE USES THEREOF | HPRT1, APRT, NUDT1 | ADORA2A 37/4885ADORA2B 51/4885TLR7 214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.